Centre for Pain Research, School of Clinical and Applied Sciences, Leeds Beckett University, Leeds, West Yorkshire, UK
Centre for Pain Research, School of Clinical and Applied Sciences, Leeds Beckett University, Leeds, West Yorkshire, UK.
BMJ Open. 2019 Oct 28;9(10):e029999. doi: 10.1136/bmjopen-2019-029999.
The aim of this systematic review with meta-analysis is to evaluate the clinical efficacy of transcutaneous electrical nerve stimulation (TENS) for any type of acute and chronic pain in adults.
We intend to search electronic databases (Cochrane Library, MEDLINE, Embase, CINAHL, PsycINFO, LILACS, PEDRO, Web of Science, AMED and SPORTDiscus) from inception to the present day to identify all randomised controlled trials (RCT) on the use of TENS in adults for any type of pain including acute pain, chronic pain and cancer-related pain. We will screen the RCTs against eligibility criteria for inclusion in our review. Two reviewers will independently undertake RCT selection, data extraction and risk of bias assessment. Primary outcomes will be: (i) participant-reported pain relief of ≥30% expressed as frequency (dichotomous) data; and (ii) participant-reported pain intensity expressed as mean (continuous) data. We will conduct meta-analyses to determine risk ratio for dichotomous data, and mean difference (MD) or standardised MD for continuous data for TENS versus placebo TENS, no treatment or waiting list control, standard of care, and other treatments. Subgroup analyses will include different pain conditions (eg, acute vs chronic), TENS intensity, during versus after TENS, TENS as a sole treatment versus TENS in combination with other treatments and TENS administered as a single dose versus repetitive dose.
This systematic review will not use data from individual participants, and the results will be disseminated in a peer-reviewed publication and presented at a conference.
CRD42019125054.
本系统评价的目的是评估经皮神经电刺激(TENS)对成人各种类型急性和慢性疼痛的临床疗效。
我们计划从一开始到现在搜索电子数据库(Cochrane 图书馆、MEDLINE、Embase、CINAHL、PsycINFO、LILACS、PEDRO、Web of Science、AMED 和 SPORTDiscus),以确定所有关于 TENS 用于成人各种类型疼痛(包括急性疼痛、慢性疼痛和癌症相关疼痛)的随机对照试验(RCT)。我们将根据纳入本综述的标准筛选 RCT。两名审查员将独立进行 RCT 选择、数据提取和偏倚风险评估。主要结局将是:(i)≥30%的参与者报告的疼痛缓解频率(二分类数据);(ii)参与者报告的疼痛强度均值(连续数据)。我们将进行荟萃分析,以确定 TENS 与安慰剂 TENS、无治疗或等待名单对照、标准护理以及其他治疗相比,二分类数据的风险比,以及连续数据的均数差(MD)或标准化 MD。亚组分析将包括不同的疼痛情况(例如,急性与慢性)、TENS 强度、TENS 期间与之后、TENS 作为单一治疗与 TENS 联合其他治疗以及 TENS 单次剂量与重复剂量。
本系统评价将不使用个体参与者的数据,结果将在同行评议的出版物中发表,并在会议上展示。
PROSPERO 注册号:CRD42019125054。